HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G/Wella deal

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble will make a cash only tender offer of $65.70 (€1=$1.07) per share for Wella preference shares as part of acquisition agreement. Cash only offer will speed up the tender process and regulatory clearance, P&G says. During consumer products manufacturer's March 18 announcement it would acquire Wella, company indicated it would consider offering P&G shares to Wella's preference shareholders as alternative to cash (1"The Rose Sheet" March 24, 2003, p. 3). P&G plans to submit tender offer documentation during the week of April 7, and assuming regulatory acceptance, offer is expected to commence in late April, firm adds...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel